PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 117.80
-5.00 (-4.07%)
At close: Apr 28, 2026
PsyRX CNS Bio-Tech Market Cap
PsyRX CNS Bio-Tech has a market cap or net worth of 12.05 million as of April 28, 2026. Its market cap has increased by 64.03% in one year.
Market Cap
12.05M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
117.80
Market Cap Chart
Since July 25, 2021, PsyRX CNS Bio-Tech's market cap has decreased from 329.34M to 12.05M, a decrease of -96.34%. That is a compound annual growth rate of -50.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 12.56M | 28.32% |
| Dec 31, 2025 | 9.79M | 100.78% |
| Dec 31, 2024 | 4.87M | -44.97% |
| Dec 31, 2023 | 8.86M | -64.09% |
| Dec 29, 2022 | 24.66M | -59.42% |
| Dec 30, 2021 | 60.77M | -81.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 108.44B |
| Danel (Adir Yeoshua) | 2.78B |
| Amal Holdings A.D. | 2.35B |
| BrainsWay | 1.93B |
| BioLight Life Sciences | 21.31M |
| Can-Fite BioPharma | 19.06M |
| Erika Carmel-Tech | 18.79M |
| Purple Biotech | 18.59M |